DIFFERENTIAL AND ENRICHMENT MEDIA FOR SELECTIVE CULTURE AND RECOGNITION OF YEAST SPECIES FROM CLINICAL MATERIAL

被引:11
作者
LOUWAGIE, B
SURMONT, I
VERHAEGEN, J
ODDS, F
机构
[1] UNIV HOSP ST RAPHAEL,DEPT BACTERIOL,B-3000 LOUVAIN,BELGIUM
[2] JANSSEN RES FDN,DEPT BACTERIOL & MYCOL,B-2340 BEERSE,BELGIUM
关键词
D O I
10.1007/BF02114896
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
An enrichment medium was developed and evaluated for isolation of fluconazole-resistant minority yeast species in a hospital setting. The enrichment medium was made by adding fluconazole (10 mu g/ml) to yeast nitrogen base/glucose broth. Under laboratory conditions the broth permitted detection of 20 of 20 Candida krusei isolates and 20 of 20 Candida glabrata isolates in mixtures with Candida albicans even when the Candida albicans cells outnumbered those of the other species by 1000:1. Results of culture on the enrichment medium were compared with those obtained on routine agar media and on a yeast differential agar which facilitates detection of mixed yeast species by their colony colours. Only one Candida glabrata isolate was detected on the enrichment broth but not found on routine culture of 68 yeast-positive clinical specimens. However, bacterial overgrowth in some broths may have retarded the appearance of other yeast isolates. On the yeast differential agar, 20 clinical specimens were found to contain mixtures of yeast species compared with only 2 on routine culture.
引用
收藏
页码:406 / 411
页数:6
相关论文
共 12 条
  • [1] CASASNOVAS RO, 1992, NEW ENGL J MED, V326, P891
  • [2] COSTE T, 1990, Bulletin de la Societe Francaise de Mycologie Medicale, V19, P151
  • [3] DUPONT B, 1992, J MED VET MYCOLOGY, V26, P67
  • [4] THE EFFECT OF FLUCONAZOLE AS PROPHYLAXIS FOR NEUTROPENIC PATIENTS ON THE ISOLATION OF CANDIDA SPP FROM SURVEILLANCE CULTURES
    ELLIS, ME
    QADRI, SMH
    SPENCE, D
    HALIM, MA
    ERNST, P
    CLINK, H
    BAILLIE, F
    DEVOL, EB
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (06) : 1223 - 1228
  • [5] DEVELOPMENT OF RESISTANCE IN CANDIDA ISOLATES FROM PATIENTS RECEIVING PROLONGED ANTIFUNGAL THERAPY
    FANHAVARD, P
    CAPANO, D
    SMITH, SM
    MANGIA, A
    ENG, RHK
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) : 2302 - 2305
  • [6] FLUCONAZOLE IN THE TREATMENT OF OROPHARYNGEAL CANDIDOSIS IN HIV-POSITIVE PATIENTS
    JUSTNUBLING, G
    GENTSCHEW, G
    DOHLE, M
    BOTTINGER, C
    HELM, EB
    STILLE, W
    [J]. MYCOSES, 1990, 33 (9-10) : 435 - 440
  • [7] Millon L., 1994, Journal de Mycologie Medicale, V4, P90
  • [8] Odds F., 1988, CANDIDA CANDIDOSIS, P68
  • [9] EFFECTS OF TEMPERATURE ON ANTICANDIDA ACTIVITIES OF ANTIFUNGAL ANTIBIOTICS
    ODDS, FC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (04) : 685 - 691
  • [10] CHROMAGAR CANDIDA, A NEW DIFFERENTIAL ISOLATION MEDIUM FOR PRESUMPTIVE IDENTIFICATION OF CLINICALLY IMPORTANT CANDIDA SPECIES
    ODDS, FC
    BERNAERTS, R
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (08) : 1923 - 1929